2019
Examining Race as a Predictor and Moderator of Treatment Outcomes for Binge-Eating Disorder: Analysis of Aggregated Randomized Controlled Trials
Lydecker JA, Gueorguieva R, Masheb R, White MA, Grilo CM. Examining Race as a Predictor and Moderator of Treatment Outcomes for Binge-Eating Disorder: Analysis of Aggregated Randomized Controlled Trials. Journal Of Consulting And Clinical Psychology 2019, 87: 530-540. PMID: 31008634, PMCID: PMC6589831, DOI: 10.1037/ccp0000404.Peer-Reviewed Original ResearchConceptsBinge-eating disorderWhite participantsCognitive behavioral therapySelf-report measuresTreatment outcomesBinge-eating remissionModerate treatment outcomeBinge Eating DisorderBinge-eating episodesMain effectBlack participantsWeight lossBehavioral weight lossEvidence-based treatmentsLower depressionTreatment researchRandomized Controlled TrialsBetter treatment outcomesControl conditionParticipantsControlled TrialsMultimodal treatmentPercent weight lossPatient groupModerator
2013
Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: Randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as
Grilo CM, White MA. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: Randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as. Behaviour Research And Therapy 2013, 51: 167-175. PMID: 23376451, PMCID: PMC3666334, DOI: 10.1016/j.brat.2013.01.002.Peer-Reviewed Original ResearchConceptsCommunity mental health centerMental health centersPlacebo-controlled trialBehavioral weight lossAddition of orlistatHealth centersRandomized placebo-controlled trialTreatment studiesWeight lossComplex patient groupNon-BED groupObesity Treatment StudyNegative prognostic indicatorHigh rateModerate treatment outcomeRemission rateObese patientsPlacebo medicationDiabetes preventionMixed-model analysisPatient groupObesity treatmentPrognostic indicatorTreatment outcomesEfficacy trials